Why the study?
Does RGS6 genetic manipulation affect cardiac hypertrophy and remodeling in response to pressure overload or angiotensin II?
Population
Failing human hearts, hypertrophic murine hearts, cardiac-specific RGS6 knockout mice, transgenic mice with…
Comparison
Genetic manipulation of RGS6 and exposure to… vs Control/wild-type mice and cardiomyocytes
Design
Preclinical
Authors
Loading...
RGS6-ASK1 merits target validation in pressure-overload remodeling; animal findings leave human translation open.
Does RGS6 genetic manipulation affect cardiac hypertrophy and remodeling in response to pressure overload or angiotensin II?
RGS6 aggravates cardiac hypertrophy by interacting with apoptosis signal-regulating kinase 1, suggesting the RGS6-ASK1 pathway as a potential therapeutic target for pressure overload-driven cardiac remodeling.
Huang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: